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1. Introduction
   The shrimp culture industry is currently going through a 
period of severe crisis due to the outbreak and recurrence 
of a viral infection. For the last two decades, the discovery 
of white spot disease caused by white spot syndrome virus 
(WSSV) is regarded as the most virulent known disease, 
affecting the sustainability and growth of the global 
penaeid shrimp farming industry. WSSV is one of the most 
widely distributed virus, which ranks in the top three of 
the harmful shrimp viruses, causing immense losses in 
the shrimp population[1,2]. Due to its pathogenicity and 
epidemic nature, WSSV has been considered notifiable by 
the Office Internationale de Epizooties[3]. It is an enveloped 
non occluded DNA virus of the family Nimaviridae under 
the new genus Whispovirus and is also the most devastating 
shrimp pathogen ever isolated and studied[4]; it causes total 
mortality in a rearing stock within 3-7 d of infection in a 
culture system[5]. This virus continued to cause a direct 
loss of approximately US $ 10 billion to the native cultured 
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shrimp industry worldwide since its first appearance in 
1992[6]. WSSV has a wide host range as it has been observed 
to infect not only shrimps but also crabs and other 
arthropods such as copepods, insects and pest prawns[7]. 
The principle clinical sign of this virus infected shrimp 
will be white spots in the exoskeleton and epidermis[8]. 
Other behavioral abnormalities include a rapid reduction in 
food consumption, lethargy and reddening of appendages. 
Sardonically, till now, no effective treatment or prophylactic 
measure could be developed to manage the virus.
   Strategies for the prophylaxis and control of WSSV 
theoretically include improvement of environmental 
conditions, stocking of specific pathogen free shrimp post 
larvae and enhancement of disease resistance by using 
immunostimulants. Several plants from both terrestrial 
and marine origin have already been tested against viral 
diseases to judge its immunostimulant efficacy. Aqueous 
extracts of Cynodon dactylon (C. dactylon) (terrestrial plant) 
and Ceriops tagal (C. tagal) (mangrove) exhibited protective 
effects against WSSV in Penaeus monodon (P. monodon)
[9-11]. The aqueous extract of Sargassum weighti (seaweed) 
showed significant anti-WSSV property against marine 
shrimp, Penaeus indicus and freshwater crab, Paratelphusa 
hydrodomous[12]. The extract of Phyllanthus amarus and 
Psidium gugajava has shown antiviral activity against 
yellow head baculovirus in P. monodon[13]. The extract 
of Clinacanthus nutans has been tested against yellow 
head virus in shrimp and the results indicated an effective 
control of yellow head virus infection in shrimp[14]. Other 
control measures that have been undertaken against the 
WSSV virus in the culture systems are oral administration 
of peptidoglycan, lipopolysacharides, β-1,3-Glucan, 
vaccination with inactivated viral preparation and viral 
envelope protein, VP19 and VP28, feeding with fucoidan 
extracted from Sargassm polycysticus and antiviral drug 
supplemented with Spirulina platensis[15-22]. An aqueous 
preparation of a composite mixture of seven Indian 
medicinal plants (Aegle marmelos, Allium sativum, Curcuma 
longa, C. dactylon, Lantana camara, Mimosa pudica, 
Ocimum sanctum) has been developed and patented in 2002, 
with the conclusion that the preparation was effective in 
controlling WSSV at the rate of 15 mg/L[23].
   Marine plants are used in folk and Ayurvedic (herbal) 
medicines in several parts of the world. Several reports 
have appeared in literature over a period of time stating 
the use of aqueous extracts of various plant species against 
enveloped, non-enveloped, DNA/RNA viruses and their 
mode of action against these pathogens. Marine algae 
have exhibited their potential as important sources of 
antiviral and other bioactive compounds[24]. Some of the 
Indian marine plants have shown antiviral activity against 
Newcastle disease virus, anti-vaccinia virus, Semliki forest 
virus, human immunodeficiency virus, hepatitis B virus, 
encephalomyocarditis virus and herpes simplex virus I[25-
31]. The antiviral activity of a polysaccharide isolated from 
a mangrove plant Rhizophora apiculata against HIV in MT-4 
cells was also demonstrated previously[32]. For several years, 
mangroves, seagrasses and seaweeds have been in focus, as 
they are a rich storehouse of phytomolecules with several 
biological activities. The uniqueness of these phytomolecules 
that are derived from these plants has prompted us to take 
up this present investigation, for which we have selected 
30 plants exclusively from different marine ecosystems like 
mangroves, seagrass, seaweed, etc. The leaves from each of 
these plants were studied for their anti-WSSV property in the 
host, Litopenaeus vannamei (L. vannamei).
2. Materials and methods
2.1. In vivo anti-WSSV activity of marine plants
2.1.1. Selection of marine plants
   Thirty marine plants selected for the present study were 
collected from different parts of the east coast of India, 
namely Sunderban, Digha, Konark, Vishakapatnam, 
Kakinada, Parangipettai, Pichavaram, Mandapam and 
Tuticorin. The plants such as Avicennia marina, Avicennia 
officinalis, Bruguiera gymnorrhiza, Heritiera fomes, 
Lumnitzera racemosa, Nypa fruticans, Rhizophora mucronata 
(R. mucronata), Sonneratia caseolaris, Sonneratia griffithii, 
Citrullus colocynthis, Derris scandens, Ipomoea pes-caprae, 
Sesuvium portulacastrum, Suaeda monoica, Tamarix troupii, 
Halodule pinifolia, Porteresia coarctata, Caulerpa racemosa, 
Chaetomorpha crassa, Enteromorpha intestinalis, Ulva 
fasciata, Ulva lactuca, Padina tetrastromatica, Sargassum 
prismaticum, Sargassum wightii, Turbinaria conoides, 
Amphiroa fragilissima, Catenella repens, Gelidium pusillum 
and Gracilaria corticata were selected for preliminary 
screening against WSSV based on the criteria such as, 
random collection of plants followed by mass screening; 
selection based on ethnomedical and ethnopharmacological 
uses in the management of diseases; follow-up of existing 
literature leads; chemotaxonomic approaches and easy 
availability of the plants for its evaluation[33,34]. The plants 
belong to diverse categories of marine ecosystem such as 
mangroves, mangrove associates, seagrass and seaweed. 
All the marine plants were personally identified by Dr. 
Kumudranjan Naskar, National Fellow, ICAR, Govt. of India. 
The voucher specimens were preserved in the herbarium 
and deposited in our laboratory.
2.1.2. Preparation of plants isolates
   Fresh leaves of these above enlisted plants were collected 
and washed thoroughly with tap water to remove the dust 
particles followed by sterile distilled water. The washed plant 
parts were also surface sterilized with calcium hypochlorite 
before they were kept aside for shade-drying for not more 
than 3-4 d depending upon the nature of the plant. The 
completely dried up leaves were ground, powdered and 
kept in air tight polythene bags until used for the extraction 
process. For the extraction process, 200 g of plant powder 
were extracted using 800 mL of different solvents like water, 
ethanol, methanol and hexane subsequently (i.e. in the 
decreasing order of polarity) as the nature of the solvent 
used in the Soxhlet extraction method affecting the nature of 
the crude extract[33]. The liquid extracts thus obtained were 
filtered through Whatman No.1 filter paper and evaporated 
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to dryness in a vacuum evaporator at 40 °C and 25–30 mmHg. 
Thus, the respective crude plant isolates obtained from 
the above procedure were coded, viz. MP01A, MP01B, MP01C, 
MP01D; likewise, MP, A, B, C & D represents marine plant, 
water, ethanol, methanol and hexane respectively. A total of 
120 plant isolates thus prepared were tested for anti–WSSV 
activity.
2.1.3. Collection and maintenance of experimental animals
   L. vannamei (4-5 g) were collected from grow-out ponds 
(near Marakkanam, Pondicherry) and maintained in 1 000 
litre fibreglass tanks containing natural seawater with airlift 
biological filters at room temperature (27–30 °C) and salinity 
(20 to 21 ppt). During the experimental trials, in each of the 30 
liter capacity plastic tank, 5 shrimps (4-5 g) were maintained 
in sea water (20 ppt). Proper aeration was provided and 10% 
water exchange was done regularly in the tanks. The shrimps 
were fed with artificial pellet feed (CP feed, Thailand). The 
water quality parameters such as temperature (28±2) °C and 
pH (7.9±0.1) were recorded and the salinity was measured 
with a refractometer (Erma Inc, Tokyo).
2.1.4. Preparation of viral inoculum
   WSSV infected L. vannamei with prominent white 
spots were collected from shrimp farms located in 
Cuddalore district, Tamil Nadu. Gills and soft parts of the 
cephalothorax region (500 mg) from these infected shrimps 
were macerated in 10 mL cold NTE buffer (0.2 mol/L NaCl, 
0.02 mol/L Tris–HCl and 0.02 mol/L EDTA, pH 7.4) with glass 
wool to a homogenous slurry using mortar and pestle in 
ice bath. The slurry was centrifuged at 3 000 r/min for 20 
min in a refrigerated centrifuge at 4 °C. The supernatant 
was recentrifuged at 8 000 r/min for 30 min at 4 °C and the 
final supernatant fluid was filtered through a 0.4 μmol/L 
filter. The preparation was streaked on Zobell’s Thiosulfate 
Citrate Bile Salts - Sucrose and potato dextrose agar plates 
and were incubated at (28±2) °C for 72 h to confirm the 
absence of microbial contamination. The viability of WSSV 
in the prepared inoculum was tested by injecting 10 μL to a 
batch of apparently healthy shrimps (4 nos) whose mortality 
occurred over a period of 3 to 5 d and the viral infection was 
confirmed by polymerase chain reaction (PCR) results. The 
viral inoculum was stored at - 20 °C until further use.
2.1.5. Virucidal activity of different plant isolates and their 
molecular diagnosis in animal model
   Different plant isolates prepared were tested against WSSV 
in L. vannamei. The inactivation of WSSV was confirmed 
by bioassay and PCR analysis. For bioassay, three tanks 
[positive control (POS), negative control (NEG) and test (TS)] 
were separately maintained for each of the 120 plant isolates. 
Each crude plant isolate was dissolved in NTE buffer, 
termed as plant isolate-buffer solution, at the concentration 
of 10 mg/mL (500 mg/kg body weight of shrimp). During 
the experimental trials, shrimps (TS) (five animals in each 
tank) were injected intramuscularly with a mixture of viral 
suspension and the above prepared plant isolate at the 
volume of 25 μL per animal (5 μL of viral suspension, 20 μL 
of plant isolate - buffer solution). The POS was injected with 
a mixture of 20 μL NTE buffer and 5 μL viral suspensions 
whereas the NEG was injected with 25 μL NTE buffer only. 
All these mixtures were incubated at 29 °C for 3 h before 
the experimentation. The experimental trial was carried 
up to 15 d after post infection with WSSV. During this 
period, mortalities were recorded for each day along with 
the constant monitoring of the viral infection using WSSV-
Shrimple test kit. 
   Gill tissues from the experimental shrimps (POS, NEG, 
TS) were dissected out and homogenized with 500 μL of 
guanidine hydrochloride buffer (10 mmol/L Tris–HCl, pH 8.0, 
0.1 mol/L EDTA, pH 8.0, 6 mol/L guanidine hydrochloride 
and 0.1 mol/L sodium acetate) in a glass homogenizer. The 
homogenate was allowed to react for 30 min after thorough 
mixing with buffer. The mixture was centrifuged at 5 000 r/
min for 5 min and the supernatant fluid was collected in a 
fresh microcentrifuge tube. To this supernatant fluid, an 
equal volume of ice-cold ethanol was added and mixed 
thoroughly. The mixture was subjected to centrifugation at 
14 000 r/min for 20 min. The pellet obtained was washed once 
with 200 μL of 95% ethanol followed by one more wash with 
200 μL of 70% ethanol. The DNA pellet was dried in a vacuum 
drier and dissolved in 50 μL sterile distilled water. This DNA 
was used as the template for the PCR. The presence of WSSV 
was confirmed by PCR using the primer designed by earlier 
researchers to amplify the 211 bp sequence of WSSV-DNA[35]. 
The sequences of the primer are Forward - 5′ GAA ACT ATT 
GAA AAG GCT TTC CCT 3′ and Reverse - 5′ GTT CCT TAT TTA CTA 
CTA CGG CAA 3′. 
   The PCR kit contents were 2 μL of template DNA, 1 μmol/L 
of each primer, 200 μmol/L of deoxynucleotide triphosphate 
and 1.25 IU of Taq DNA polymerase in PCR buffers supplied 
with a commercially available kit. The mixture was 
incubated for 35 cycles in an automatic thermal cycler 
programmed for 0.5 min at 95 °C, 1 min at 55 °C and 1 min 
at 72 °C, following by extension for 5 min at 72 °C after the 
last cycle. After the PCR run, the amplified products were 
analyzed by electrophoresis in 1.2% agarose gel stained 
with ethidium bromide and visualized by ultraviolet 
transillumination.
2.2. Confirmation of anti-WSSV activity of the final plant 
isolate in animal model
   Fresh leaves of R. mucronata were collected, shade dried 
and coarsely powdered. About 1 kg of leaf powder was 
extracted by water and ethanol in succession using a Soxhlet 
apparatus[36]. The yield of water extract (MP07A-brownish red 
in colour) and the ethanolic extract (MP07B-deep green in 
colour) was 24.8% and 19.2% respectively, which were further 
condensed in a rotary evaporator. Both the syrupy extracts 
were mixed together, diluted in 200 mL 100% ethanol in a 
glass bottle and shaken vigorously. A copious quantity of gel 
like precipitate was formed immediately after the addition 
of ethanol. The supernatant was recovered by filtration and 
the gel pellet was discarded. The extracts thus obtained 
(MP07X–deep greenish red in colour) were filtered through 
Whatman (No. 1 filter paper) and were evaporated to dryness 
in a vacuum evaporator at 40 °C and 25–30 mmHg. The yield 
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of MP07X was 38.2% from powdered leaves. The dried plant 
isolate/crude drug (MP07X) was stored in the refrigerator and 
was used in all the analysis and experiments hereafter. 
   The crude drug (MP07X) was tested by injecting the host 
intramuscularly against WSSV to confirm its efficacy as a 
potent anti–WSSV drug. The same methodology was followed 
as described in section 2.1.5. above, and the nested PCR 
results are illustrated. The experimentation was carried 
on for 15 d and the survival percentage was also recorded. 
After 15 d, DNA was extracted from the surviving shrimp to 
check its viral load and the same was injected to fresh sets 
of shrimps. All the samples were subjected to nested PCR, 
using WSSV nested PCR kit (Bangalore Genei, India).
2.3. Optimization of MP07X as an anti–WSSV drug in animal 
model
2.3.1. Determination of the viral titer of WSSV using L. 
vannamei as the animal model
   The viral stock prepared from 500 mg freshly infected first 
step PCR positive tissue in 10 mL NTE buffer was diluted from 
1伊10
-1 to 1伊10-6. Apparently, healthy shrimps (four animals 
in a tank in triplicate) were injected with 10 μL suspensions 
from all the dilutions having the NEG maintained by 
administering with the same quantity of NTE buffer. The 
animals were observed for mortality every day for 7 d. The 
highest dilution at which 100% mortality of the test animals 
was obtained and selected for all the further bioassays. The 
percentage of mortality obtained with different dilutions of 
virus on different days after the intramuscular challenge was 
statistically analyzed by ANOVA, and the differences were 
considered significant at P≤0.05.
2.3.2. Toxicity of the plant isolate in animal model
   The lyophilized plant isolate (MP07X) was used to prepare 
the strength solution for toxicity studies in L. vannamei (6–8 
g) as the animal model. The stocks having strength of 5, 10, 
15, 20, 25, 30, 35, 40, 45 and 50 mg/mL were prepared in NTE 
buffer. From each of the preparations, aliquots of 10 μL were 
administered intramuscularly at the 6th abdominal segment 
of apparently healthy L. vannamei. The control consisted 
of animals injected with 10 μL of distilled water. For every 
concentration of the extract, six animals each were used in 
triplicates and they were monitored for 7 d and subjected for 
general health assessment such as characteristic colouration, 
feed intake, moulting, antenal intactness and necrosis. The 
percentage of survivability obtained with different dilutions 
of the extract was statistically analyzed by a single factor 
ANOVA. The differences were considered significant at 
P≤0.05.
 
2.3.3. Strength of the plant isolate (MP07X) required for 
virucidal activity
   Various concentrations of the plant isolate (MP07X) (35, 
30, 25, 20, 15, 10 and 5 mg/mL) were prepared and mixed 
with 1伊10-1 dilution of the viral suspension at a ratio of 
1:1 and incubated at 28 °C for 3 h. As a NEG was only NTE 
buffer and the POS was the viral suspension mixed with 
NTE buffer at a ratio of 1:1, they were incubated under the 
same conditions as given to the test. After the incubation, 
25 μL aliquots (each of the above preparations) were 
injected intramuscularly to a batch of 9 apparently healthy 
L. vannamei (6-8 g) in triplicates into their 6th abdominal 
segment i.e. the animals were injected with a quantity of 
1 750 mg, 1 500 mg, 1 250 mg, 1 000 mg, 750 mg, 500 mg, and 250 
mg of MP07X/kg body weight/day respectively. The animals 
were monitored for clinical signs of white spot disease and 
mortality. The percentage of survivability obtained in the 
administration of different concentrations of the extract 
was statistically analyzed by a single factor ANOVA and 
the differences were considered significant at P≤0.05.
2.3.4. Preparation of WSSV infected tissue for oral challenge
   Apparently, healthy L. vannamei (6-8 g) were challenged 
by injecting them intramuscularly with 10 μL of a 1伊10-1 
dilution of the viral suspension. The animals were monitored 
for the development of clinical signs and mortality for 7 d. 
All dead or moribund animals were collected and subjected 
to PCR for the detection of WSSV following the procedure 
described earlier. The PCR products were analyzed on a 
1% w/v agarose gel using TAE buffer stained with ethidium 
bromide and visualized using a gel documentation system, 
Dolphin-Doc (Weal Tec, USA). Animals that were tested 
positively were segregated, and its soft tissues from the 
cephalothorax were minced and stored at - 80 °C in 1 g 
aliquots for oral challenge experiments.
2.3.5. Quantitative determination of the plant isolate 
(MP07X) for protection of shrimp from WSSV
   To determine the quantity of the plant isolate (MP07X) 
required for protecting the shrimps against WSSV, the 
animals (TS) were fed with different concentrations of 
the same for a period of 7 d prior to the challenge. To 
accomplish this objective, artificial medicated shrimp feed 
was produced with MP07X at 3.0%, 2.5%, 2%, 1.5%, 1% and 
0.5% of the feed i.e., the shrimps were fed with a quantity 
of 1 500 mg, 1 250 mg, 1 000 mg, 750 mg, 500 mg, and 250 mg 
of MP07X/kg body weight/day respectively. The POS and NEG 
shrimps consumed feed without MP07X. On the 8th day, 
both the TS samples and POS shrimps were challenged by 
feeding them with freshly generated WSSV positive tissue at 
0.25 mg/shrimp, and continued with the feed (in case of TS, 
medicated feed), and were observed for clinical signs of the 
disease and mortality for 7 d. The percentage of survivability 
obtained with different concentrations of the extract was 
statistically analyzed by a single factor ANOVA and the 
differences were considered significant at P≤0.05.
2.4. Reverse transcription PCR analysis of various genes 
expressed during the host pathogen interaction
   The expressions of the genes on the 42nd hour and 84th 
hour after the challenge with the virus were examined to 
find out whether the plant isolate (MP07X) was inhibiting 
the processes involved in the viral multiplication cycle 
during host pathogen interaction. Gill tissue from shrimps 
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representing each group (POS, NEG & TS) was taken for their 
RNA extraction. About 100 mg of gill tissue was macerated 
in 1 000 μL TRIzol Reagent. The sample was kept for 5 min 
at room temperature to ensure complete dissociation of 
nucleoprotein complexes. A total of 0.2 mL of chloroform 
was added to 1 000 μL TRIzol Reagent and shaken vigorously 
for 15 seconds and then allowed to stand for 15 min at 
room temperature and centrifuged at 12 000 r/min for 15 
min. Colorless aqueous phase was separated carefully 
from the three layers formed to a fresh tube. About 0.5 mL 
isopropanol was added, kept for 10 min at room temperature 
and centrifuged at 12 000 r/min for 10 min at 4 °C. RNA was 
found to precipitate on the sides and bottom of the tube 
after centrifugation. The supernatant was discarded, and 
the pellet was washed twice in 75% ethanol. The RNA pellet 
was air dried and dissolved in 20 μL diethyl pyrocarbonate 
treated water by repeated pipetting at 55 °C for a while. The 
RNA was then subjected to DNase treatment with RNase-
free DNase 1. About 0.2 units of enzyme were added to 1 
μg of RNA and incubated at 37 °C for 10 min. The enzyme 
was inactivated at 75 °C for 10 min. The concentration and 
quantity of RNA were measured at 260/280 nm using UV-
Visible spectrophotometer. A total of 5 μg RNA was subjected 
to cDNA synthesis with 20 μL reaction mix containing M-MULV 
reverse transcriptase (200 IU), RNase inhibitor (8 IU), Oligo 
(dT) 12 primer (40 pmol), dNTP mix (1 mmol/L), RTase buffer 
(1伊) and MgCl2 (2 mmol/L) at 42 °C for 1 h. Then 2 WSSV genes 
immediate early gene1 (ie 1) and VP28 were amplified by 
PCR. A total of 1 μL cDNA reaction products were subjected 
to PCR amplification with the primer set VP28-F and VP28-R 
(VP28-F; 5’ – CTG CTG TGA TTG CTG TAT TT - 3’ and VP28-R; 
5’ – CAG TGC CAG AGT AGG TGA C – 3’) for the VP28 gene and 
ie 1-F and ie 1-R (ie 1 1-F; 5’ – GAC TCT ACA AAT CTC TTT GCC 
A – 3’ and ie 1-R; 5’ – CTA CCT TTG CAC CAA TTG CTA G – 3’) 
for the immediate early gene1 (ie 1). Shrimp β actin gene was 
also amplified (Forward - 5’ – CTT GTG GTT GAC AAT GGC TCC 
G – 3’ and Reverse 5’ – TGG TGA AGG AGT AGC CAC GCT C – 3’) 
for RNA quality and amplification efficiency as a reference. 
About 25 μL PCR reaction mix contained 0.5 IU of Taq DNA 
polymerase, 200 μmol/L dNTP mix, 10 pmol each of forward 
and reverse primers and 1伊 PCR buffer. The hot start PCR 
programme used for WSSV genes was 94 °C for 2 min followed 
by 35 cycles of 94 °C for 30 seconds, annealing for 30 seconds 
(54 °C for immediate early gene1 (ie 1), VP28, and 55 °C β 
actin), and extension at 68 °C for 30 seconds followed by final 
extension at 68 °C for 10 min. Each of the PCR products (10 
μL) was analyzed by 1% agarose gel electrophoresis, stained 
with ethidium bromide and visualized under ultraviolet light 
and documented.
3. Results 
3.1. In vivo anti-WSSV activity of marine plants
3.1.1. Viral inoculums for anti–WSSV assay
   The L. vannamei with prominent white spots collected 
from shrimp farms was WSSV positive. The WSSV inoculum 
obtained from these viral infected shrimps were injected to 
the fresh shrimps and the molecular diagnosis (PCR results) 
is presented in Figure 1.
   M                     1                    2                  P                      N
Figure 1. Detection of WSSV gene in the PCR product.
M=marker, 1=WSSV infected shrimp from the farm, 2=fresh WSSV infected 
shrimp produced in the laboratory, P=positive control (211 bp), N=negative 
control.
3.1.2. Virucidal activity of different plant isolates and their 
molecular diagnosis in the animal model
   To check the virucidal activity of 120 plant isolates, the 
isolates were mixed with WSSV inoculum and challenged 
after incubation for 3 h at 29 °C. When shrimps were 
challenged with WSSV mixed with the plant isolates such 
as MP02C (methanolic extract of Avicennia officinalis), MP07A 
(water extract of R. mucronata), MP07B (ethanolic extract of 
R. mucronata), MP08A (water extract of Sonneratia caseolaris), 
MP09B (ethanolic extract of Sonneratia griffithii), MP11B 
(ethanolic extract of Derris scandens), MP25B (ethanolic 
extract of Sargassum wightii), MP28C (methanolic extract 
of Catenella repens) and MP30A (water extract of Gracilaria 
corticata); then a moderately higher survival percentage 
was obtained (Figure 2). Meanwhile, the remaining plant 
isolates did not produce significant survival percentage. The 
NEG survived till the end of the experimentation while 100% 
mortality was observed in the POS within the 3rd to 4th day. 
This abundantly available mangrove plant R. mucronata 
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has derived both MP07A and MP07B isolates that have shown 
significant survivability in the shrimps. Hence, further 
experimentation was carried out to get a better survival 
percentage in the shrimps by obtaining a potent anti–WSSV 
drug from the above two isolates.
Figure 2. Detection of the virucidal property of the best nine plant isolates.
M: Marker; I: MP02C; II: MP07A; III: MP07B; IV: MP08A; V: MP09B; VI: MP11B; 
VII: MP25B; VIII: MP28C; IX: MP30A; POS: Positive; NEG: Negative.
1 000 bp
500 bp
200 bp
211 bp
M I II III IV V VI VII VIII IX POS NEG
3.2. Confirmation of anti-WSSV activity of the final plant 
isolate (MP07X) in an animal model
   The activity of the plant isolate/crude drug (MP07X) was 
examined against WSSV in L. vannamei to confirm its 
efficacy as a potent anti–WSSV drug. On completion of the 
experiment, after 15 d the shrimps were nested PCR negative, 
and when the DNA extracted for virus from these shrimps 
were injected into a fresh batch of shrimps none of them 
showed any clinical signs of WSSV infection and remained 
negative to nested PCR (Figure 3). The survivability was 85% 
at the end of the 15th day of the experimentation (Figure 4). 
Figure 3. PCR diagnosis of MP07X in shrimps.
M=marker, 1=WSSV negative (MP07X intramuscular injection), 2=WSSV 
negative (lane 1 DNA injected to fresh shrimps), N=negative control (NEG), 
P=positive control (POS).
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Figure 4. Survival percentage of L. vannamei when subjected to MP07X.
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3.3. Optimization of MP07X as an anti–WSSV drug in animal 
model
3.3.1. Virulence of WSSV in animal model
   To determine the virus titer required to cause mortality 
of shrimp within a period of 7 d on intramuscular 
administration, different dilutions of WSSV in NTE buffer 
were injected and observed for mortality (n=4). The 
difference in mortality occurred in shrimp which received 
varying dilutions of the virus and was highly significant 
(P<0.001). Among the dilutions, 1伊10-1 and 1伊10-2 resulted in 
mortality of all animals within 6 d (P<0.001), and from the 
dilution 1伊10-6 onwards no mortality could be registered, 
and the animals behaved as NTE buffer injected shrimps 
(P<0.001) (Figure 5).
Figure 5. Percentage of mortality with different titers of virus 
intramuscularly injected.
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3.3.2. Determination of in vivo toxicity of the plant isolate
   L. vannamei (6-8 g) (n=6) were injected with the plant 
isolate at different concentrations ranging from 5-50 mg/
mL and monitored for 7 d (Figure 6). The response of the 
animals was more or less the same without any significant 
mortality even up to a concentration of 35 mg/mL (P<0.05). 
However, at 50 mg/mL strength there was significant 
reduction (56% average percentage survival) (P<0.05) in 
survival of shrimps during the experimental period of 7 d.
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Figure 6. Toxicity of different concentration of plant isolate (MP07X) in L. 
vannamei.
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3.3.3. Strength of the plant isolate required for virucidal 
activity
   The experiments to determine the virucidal activity were 
carried out on L. vannamei (6-8 g) (n=9), by administering 
WSSV at a dilution of 1伊10-1 after exposing the shrimps to 
different concentrations of MP07X at equal proportions for 3 
h at 29 °C. There were significantly higher (P<0.001) survival 
rate of shrimps when administered with WSSV suspension 
exposed to higher concentrations of MP07X such as 10–35 
mg/mL. Accordingly, the shrimps did not get infected with 
these above concentrations registering an overall survival 
rate of 85%. Meanwhile, the batches of shrimp administered 
with 5 mg/mL of MP07X resulted in a lesser survival rate 
of 64% respectively. All POS succumbed to the virus when 
administering with the virus exposed to NTE buffer after 
incubation for 3 h at 29 °C. All NEG survived the entire 
experimental period (Figure 7).
Figure 7. Virucidal property at different concentration of plant isolate 
MP07X.
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3.3.4. Quantitative determination of plant isolate (MP07X) for 
protection of shrimp against WSSV
   To examine the in vivo antiviral activity of the plant 
isolate, L. vannamei (6-8 g) (n=6) were fed with pellet feed 
at 1 500 mg/kg, 1 250 mg/kg, 1 000 mg/kg, 750 mg/kg, 500 mg/
kg, and 250 mg/kg body weight/day for a period of 7 d. On 
challenging all the batches of shrimp by oral administration 
of freshly infected tissue, all animals that received MP07X at 
a dosage of 1 000 mg/kg body weight/day survived at 85%, and 
the differences in survivability between different batches 
were significant (P<0.001). Significantly, lower average 
survival rates of shrimps were observed in the batches that 
received 750, 500 and 250 mg/kg body weight/day as the 
average survival rate was only 65%, 57%, and 33%. The POS 
(shrimps supplemented with normal diet and challenged 
with WSSV) succumbed to WSSV registering total mortality. 
All NEG animals survived (Figure 8).
Figure 8. Efficacy of orally administered extract against WSSV.
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3.4. Reverse transcription PCR analysis of various genes 
expressed during the host pathogen interaction
   The expressions of the genes on the 42nd hour and 84th 
hour after the challenge with the virus were examined to 
find out whether the plant isolate (MP07X) was inhibiting the 
processes involved in the viral multiplication cycle during 
host pathogen interaction. The gene expression study was 
conducted in three groups (POS, NEG and TS) of animals. 
Viral genes were not amplified in the TS group of animals 
and appeared exactly like the NEG. In the case of POS, the 
viral genes such as immediate early gene (ie 1) and VP28 
were found to be expressed at both 42nd hour and 84th hour 
after challenge with WSSV. It was observed that, as the time 
passed by, there was an increase in the intensity of bands of 
these genes suggesting more multiplication of the virus in 
the POS shrimps (Figure 9).
Figure 9. Reverse transcription PCR analysis of VP28, immediate early (ie 1) 
and β actin genes in host.
VP28 gene
ie 1 gene
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555 bp
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  M       Ts     Neg     Pos          M       Ts     Neg     Pos
β actin gene
 
   In the case of POS animals which received the virus 
intramuscularly, total mortality was observed at the 84th 
hour itself. Hence, animals were not available to assay 
beyond that timeline.
4. Discussion
   Most of the products derived from marine organisms show 
many interesting activities. Their constituents are more 
novel than those of the terrestrial plants. Seaweeds have 
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long been recognized as rich and valuable natural resources 
of bioactive compounds because of their various biological 
properties[37]. The water soluble extracts of seaweeds have 
been shown to exhibit antiviral activity against a wide 
spectrum of viruses[38]. Extracts from mangrove plants and 
its associates have been used worldwide for medicinal 
purposes and also as a producer of around 349 metabolites, 
which turns out to be a rich source of steroids, diterpenes, 
triterpenes, saponins, flavanoids, alkaloids and tannins[39-
42]. Marine algae have shown their potential as important 
sources of antiviral as well as other bioactive compounds[24].
   In this present study, an attempt has been made to look 
into the possibilities of using marine plants as sources of 
anti-WSSV drugs. With this objective, 30 marine plants 
abundantly found in different marine ecosystems of east 
coast of India were subjected to Soxhlet extraction to 
procure a combination of phytomolecules, potent enough to 
be an anti-WSSV drug and at the same time applied along 
with diet as a prophylactic measure. In this study, MP02C, 
MP07A, MP07B, MP08A, MP09B, MP11B, MP25B, MP28C and MP30A 
were found to be effective against WSSV. Both the isolates 
MP07A and MP07B derived from the same plant that showed 
significant survivability, and the plant was abundantly 
available. Hence, further experimentation was carried out to 
get a better survival percentage in the shrimps by obtaining 
a potent anti–WSSV drug from the above two isolates. The 
final plant isolate MP07X proved to be the potent anti–WSSV 
drug in our research. As MP07X alone could give protection 
to all animals tested against WSSV, under the experimental 
conditions, this plant species (R. mucronata) was identified 
for further studies. Under the conditions of feeding, when 
the medicated feed administered with subsequent challenge, 
the viral DNA was not detected in the tissue which suggested 
that the virus had either not invaded the host tissue and 
multiplied or gotten eliminated subsequent to the infection.
   Several attempts have been made earlier by several 
workers to detect anti-WSSV property in plants. Previously, 
the methanolic extracts of five medicinal plants such as C. 
dactylon, Aegle marmelos, Tinospora cordifolia, Picrorhiza 
kurooa and Eclipta alba were mixed together in equal 
proportions, and the combined extracts were supplemented 
through the shrimp diet at different concentrations[43]. In 
administering the extract at 800 mg/kg body weight/day, 
74% of P. monodon was obtained. In a similar study, the 
percentage survivability of shrimp fed on the ethanolic leaf 
extract of the terrestrial plant (Pongamia pinnata) was 40% 
on administering at 200 mg/kg of body weight and 80% on 
administering at 300 mg/kg body weight/day[44]. On feeding 
P. monodon with 2% aqueous extract of C. dactylon, coated 
feed could obtain 100% survival rate and at the same time 
the live animals were PCR negative[10]. There were reports 
of feeding P. monodon with diet containing extracts of 
herbs which have improved their immune system and also 
accorded protection against WSSV[43]. Approximately 100% 
survivability of P. monodon was obtained on feeding with 
1% aqueous extract of C. tagal at 500 mg/kg of body weight/
day[11]. Virucidal property of the aqueous extracts of R. 
mucronata, Sonneratia sp. and C. tagal when administered 
along with WSSV suspension in 1:1 ratio after incubation 
for 3 h at 25 °C suggested the presence of molecules in the 
preparation which could inactivate the virus. In a similar 
pattern, preincubation of WSSV with a synthetic antibacterial 
peptide from Mytillus galloprovincialis reduced mortality 
due to WSSV in Palaemonid shrimp Palaemon sp[45]. They 
suggested that this might be due to contact of virus with 
mytilin before injection into shrimp. PCR analysis showed 
that the surviving animals were not accommodating the viral 
DNA.
   The plant that has been identified earlier as a 
potential source of antiviral drug belongs to the family 
Rhizophoraceae[32]. The present study also points out that 
the mangrove plant R. mucronata belonging to family 
Rhizophoraceae is a potential source of virus inactivating 
agents. Antiviral activities of aqueous extracts from plants 
are well established and this includes reports on the antiviral 
activity of plant extracts against WSSV, too[9-11,21,43,46-53]. A 
combination of herbal extracts and probiotics as medicated 
diet could decrease prevalence of WSSV in L. vannamei[54]. 
Even though reports are available on the protective effect 
of plant extracts against WSSV, information on their mode of 
action are scanty. In this study, antiviral property of MP07X 
was investigated employing molecular tools, evaluating 
their role in protecting shrimps from WSSV. The titer of 
WSSV stock used for the experiment was determined in vivo 
animal model so as to have adequate virus load to initiate an 
infection. Accordingly, the viral suspension was prepared by 
macerating 500 mg of infected tissue in 10 mL buffer diluting 
to 1伊10-1 to 1伊10-6. In all the further experiments, a titer of 1
伊10-1 was used. Previous researchers also used 1伊10-1 viral 
titer in their experiments[11]. Similar kind of experiments 
were conducted to determine the dilution of WSSV required 
to be used for neutralization by WSSV vaccine[55]. According 
to them, a dilution of 1伊10-3 could cause 100% mortality 
within 7 d. In animal model, the highest non-toxic 
concentration went up to 35 mg/mL, from which 10 μL extract 
was injected to shrimps (6-8 g). Similarly, the highest non-
toxic level of C. tagal in P. monodon is 50 mg/mL[11]. The 
average percentage of survivability of shrimps injected with 
the MP07X was 85% at a concentration of 10 mg/mL. Marginal 
mortality due to cannibalism subsequent to moulting may 
be considered. Different concentrations of cidofovir (an 
antiviral drug) were injected and observed that it was non-
toxic to shrimps up to a concentration of 200 mg/kg of body 
weight and they could successfully use the same for further 
assays[22].
   Accordingly, an experiment was conducted in the present 
study to determine the lowest concentration of the extract 
required to exhibit virucidal property against WSSV in L. 
vannamei. In this experiment, a range of concentrations of 
the extract between 5 mg/mL and 35 mg/mL were chosen, 
and the concentration of above 10 mg/mL was found to 
be effective in exhibiting its virucidal property. In these 
processes, the lowest concentration required for virucidal 
property was 10 mg/mL. The result indicated that the 
minimum concentration of the extract required for extending 
the virucidal activity was less than its in vivo toxic level 
with high selectivity index, which was the ratio of toxic 
concentration to the effective concentration, and showed 
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higher antiviral activity at a concentration below the toxic 
value. The results generated unambiguously suggest that 
the virucidal property of MP07X is concentration dependent. 
In a similar pattern on screening 20 Indian medicinal 
plants, anti-WSSV activity was exhibited by the aqueous 
extract of C. dactylon on administering 100 mg/kg of body 
weight when injected intramuscularly. Dosage dependent 
antiviral effects against WSSV have been reported in the 
case of antimicrobial peptide mytilin when injected after 
incubating with WSSV[45,56]. It was proposed that the antiviral 
activity of mytilin was mediated by its binding onto the viral 
envelope[45,56].
   On evaluating effectiveness of orally administered MP07X 
through medicated feed in protecting shrimps against 
WSSV, none of the test animals exhibited signs of distress 
during the period of drug administration. Shrimps orally 
administered with MP07X at a dosage of 1 000 mg/kg of body 
weight exhibited 85% survival rate on challenging with 
WSSV infected tissue. In a comparable way, administration 
of peptidoglycan from Cladosiphon okamuranus at the 
rate of 100 mg/kg of shrimp body weight resulted in 76.2% 
survival rate and administration of fucoidan from Sargassum 
polycystum at 400 mg/kg of body weight resulted in 93% 
survival rate[21,51]. The ethyl acetate extract of Calotropis 
procera enhanced the survival rate of shrimps to 80% against 
WSSV challenge groups due to the antimicrobial factors in the 
extracts. Also it was backed by the evidence that no signal 
was obtained from molecular detections[57]. Shrimps fed with 
300 mg of Dunaliella extract per kg of feed showed higher 
resistance to WSSV infection, besides becoming tolerant to 
stress[52]. 
   To evaluate the efficacy of MP07X for protecting L. 
vannamei from WSSV infection, expression of immediate 
early gene (ie 1) and VP28 and β actin genes were investigated. 
This study indicated that the viral transcripts involved in 
viral replication were not expressed in the animals TS and 
were administered with the crude drug. This was alike 
for both the 42nd hour and 84th hour after challenge with 
WSSV. The striking observation was that immediate early 
gene (ie 1) failed to be expressed in this group of animals. 
The expression of viral immediate early gene occurs 
independently of any viral de novo protein synthesis as the 
primary response to the viral invasion[58]. Once expressed, 
the ie gene products may then function as regulatory 
transacting factors and may serve to initiate viral replication 
events during infection. Recently, it was found that WSSV 
used a shrimp STAT as a transcription factor to enhance viral 
gene expression in the host cells. STAT directly transactivates 
WSSV ie 1 gene expression and contributes to its strong 
promoter activity[59]. In the cascade of viral regulatory 
events, successive stages of virus replication are dependent 
on the proper expression of the genes in the preceding stage. 
In the present study, none of these genes, [immediate early 
gene (ie 1) and VP28] was found to be expressed. This might 
be due to inactivation of the virus by the virucidal activity 
of MP07X. The results of different types of assays, viral and 
immune gene expression and histopathology all indicated 
that shrimps were protected from disease, either because 
they were protected from infection, or because they were 
protected from early dissemination of the infection in the 
presence of the crude drug.
   The overall results suggest that the mode of action of MP07X 
against WSSV is virucidal. Consequently, the inactivated 
virus fails to multiply in the host and subsequently gets 
eliminated. Three possible modes of action of plant extracts 
against WSSV were proposed earlier[9]; (i) Viral inactivation 
due to interaction between the extract and the envelope 
protein, (ii) Influence of the plant extract on the replication 
of the virus, which prevents virus multiplication in a host 
cell, and (iii) Immunostimulatory activity of the plant extract. 
   On analyzing the results generated in this study, in the 
light of the postulates described above, it could be inferred 
that the virus was getting inactivated by the plant isolate 
and thus getting prevented from establishing an infection. 
In conclusion, through this study, we could confirm the 
antiviral activity of MP07X and could standardize the 
quantity of the plant isolate required to protect shrimps from 
WSSV infection against a defined titer of virus. We found 
that the crude drug was less toxic to the shrimps at the 
concentrations required for the antiviral activity. However, 
more studies are required to evaluate the possible mode 
of action of MP07X using different tools of biochemistry and 
molecular biology.
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Comments 
Background
   WSSV is a main threat to the shrimp farming industry as 
the virus can cause 100% mortality of the infected shrimps 
within few days. An effective inexpensive anti-WSSV drug is 
the need of the hour, in order to help the shrimp farmers.
Research frontiers
   The present research work depicts the screening of 
the marine plants for the isolation of the anti-WSSV drug 
and optimization of its dosage by administering the same 
via intramuscular and oral routes into WSSV infected L. 
vannamei, as a host.
Related reports
   Marine plants are of potent medicinal values that can be 
used to cure many diseases and disorders in human as well 
as other life forms. The plants have also derived effective 
antiviral drugs for some of the viruses of both plant and 
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animal origin.
Innovations and breakthroughs
   The effective dosage of the drug is non-toxic in nature and 
can be easily administered to the host. This study reveals 
the in vivo efficacy of the drug to combat WSSV in the host.
 
Applications
   The drug can be modified and further research is required 
in this aspect in order to make the administration of this 
drug possible into different hosts, harbouring WSSV.
Peer review
   This is a good study in which the authors have proved 
the efficacy of the marine derived anti-WSSV drug. The 
formulation of the drug is inexpensive and at the same 
time cost effective for the use of the marginal farmers. 
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